Glucine

Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. Chemically, it is 3B-lysine-29B-glutamic acid-human insulin, has the empirical formula C258H384N64O78S6 and a molecular weight of 5823. It was developed by Sanofi-Aventis and sold under the trade name Apidra®. When injected subcutaneously, it appears in the blood earlier and at higher concentrations that human insulin. When used as a meal time insulin, the dose should be given within 15 minutes before a meal or within 20 minutes after starting a meal.
See more at Wikipedia.org...

General Information:
 Chemical Formula:
CaBe4(PO4)2(OH)4·0.5(H2O)
 Composition:
(Molecular Weight = 343.11 gm)
Calcium 11.68 % Ca
Beryllium 10.51 % Be
Phosphorus 18.05 % P 
Hydrogen 1.47 % H 
Oxygen 58.29 % O 
 Empirical Formula:
CaBe4(PO4)2(OH)4·0.5(H2O)
 Environment:
In mica-fluorite veins.
 IMA Status:
Approved IMA 1963
 Locality:
Ural Mountains, Russia.
 Name Origin:
Named for the alternative name for beryllium: Glucinum.
Physical Properties:
 Color:
colorless or white.
 Density:
2.32 - 2.4, Average = 2.36
 Habits:
Massive - Fibrous - Distinctly fibrous fine-grained forms., Concretionary - Rounded massive fine-grained materials.,
 Hardness:
5 - Apatite
 Streak:
white
More details...